Detalhe da pesquisa
1.
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
N Engl J Med
; 388(8): 719-732, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795891
2.
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 23(10): 1308-1320, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36113498
3.
Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study.
Lancet Oncol
; 22(1): 98-106, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387498
4.
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Lancet
; 396(10260): 1413-1421, 2020 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002429
5.
Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone.
Radiology
; 297(3): 622-629, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078998
6.
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Lancet Oncol
; 20(11): 1531-1543, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31540791
7.
Stereotactic body radiotherapy for oligometastases.
Lancet Oncol
; 14(1): e28-37, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23276369
8.
Single tertiary cancer center experience on the management of pT3b prostate cancer after robotic-assisted laparoscopic prostatectomy.
Curr Urol
; 16(4): 227-231, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36714225
9.
Single dose high-dose-rate brachytherapy with focal dose escalation for prostate cancer: Mature results of a phase 2 clinical trial.
Radiother Oncol
; 159: 67-74, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766703
10.
Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results.
Radiother Oncol
; 154: 214-219, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33011207
11.
Ultra-hypofractionated radiotherapy for low- and intermediate risk prostate cancer: High-dose-rate brachytherapy vs stereotactic ablative radiotherapy.
Radiother Oncol
; 158: 184-190, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33639192
12.
Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer.
Radiother Oncol
; 157: 93-98, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493500
13.
Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial.
Oncologist
; 15(9): 935-43, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20798194
14.
Single dose high-dose rate (HDR) brachytherapy (BT) as monotherapy for localised prostate cancer: Early results of a UK national cohort study.
Radiother Oncol
; 143: 95-100, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32044166
15.
A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer.
Int J Radiat Oncol Biol Phys
; 72(2): 441-6, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18249501
16.
High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial.
Radiother Oncol
; 84(2): 114-20, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17531335
17.
Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer.
Radiother Oncol
; 124(1): 56-60, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28666552
18.
High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions.
Radiother Oncol
; 68(3): 285-8, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-13129636
19.
High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity.
Radiother Oncol
; 110(2): 268-71, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24231242
20.
Dosimetric predictors of biochemical control of prostate cancer in patients randomised to external beam radiotherapy with a boost of high dose rate brachytherapy.
Radiother Oncol
; 110(1): 110-3, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24100150